Near Infrared‐Triggered Nitric Oxide‐Release Nanovesicles with Mild‐Photothermal Antibacterial and Immunomodulation for Healing MRSA‐Infected Diabetic Wounds

Chang Xu,Jiqing Zhang,Junxian Zhang,Danting Li,Xiaozhe Yan,Yuxuan Gu,Meihui Zhong,Hui Gao,Qiang Zhao,Xiongwei Qu,Pingsheng Huang,Jimin Zhang
DOI: https://doi.org/10.1002/adhm.202402297
IF: 10
2024-08-25
Advanced Healthcare Materials
Abstract:A near‐infrared‐triggered NO release and photothermal system (Au/PEL‐PBA‐MB/PArg) is constructed. With the use of phenylboronic acid specifically to capture bacteria, NO displayed superior mild PTT against MRSA and, thus, suppressed MRSA‐induced excessive inflammation. NO then relays the immunomodulated macrophage polarization toward M2, and inflammation is transferred for repair. In cooperation with NO angiogenesis during repair, tissue regeneration in MRSA‐infected diabetic wounds is accelerated. Bacterial infection‐induced excessive inflammation is a major obstacle in diabetic wound healing. Nitric oxide (NO) exhibits significant antibacterial activity but is extremely deficient in diabetes. Hence, a near‐infrared (NIR)‐triggered NO release system is constructed through codelivery of polyarginine (PArg) and gold nanorods (Au) in an NIR‐activatable methylene blue (MB) polypeptide‐assembled nanovesicle (Au/PEL‐PBA‐MB/PArg). Upon NIR irradiation, the quenched MB in the nanovesicles is photoactivated to generate more reactive oxygen species (ROS) to oxidize PArg and release NO in an on‐demand controlled manner. With the specific bacterial capture of phenylboronic acid (PBA), NO elevated membrane permeability and boosted bacterial vulnerability in the photothermal therapy (PTT) of the Au nanorods, which is displayed by superior mild PTT antibacterial activity against methicillin‐resistant Staphylococcus aureus (MRSA) at temperatures
nanoscience & nanotechnology,engineering, biomedical,materials science, biomaterials
What problem does this paper attempt to address?